Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study

 

 Permissions and Reprints

Abstract

Background Lymph node metastasis (LNM) is possible after endoscopic resection of early esophageal adenocarcinoma (EAC). This study aimed to develop and internally validate a prediction model that estimates the individual risk of metastases in patients with pT1b EAC.

Methods A nationwide, retrospective, multicenter cohort study was conducted in patients with pT1b EAC treated with endoscopic resection and/or surgery between 1989 and 2016. The primary end point was presence of LNM in surgical resection specimens or detection of metastases during follow-up. All resection specimens were histologically reassessed by specialist gastrointestinal pathologists. Subdistribution hazard regression analysis was used to develop the prediction model. The discriminative ability of this model was assessed using the c-statistic.

Results 248 patients with pT1b EAC were included. Metastases were seen in 78 patients, and the 5-year cumulative incidence was 30.9 % (95 % confidence interval [CI] 25.1 %–36.8 %). The risk of metastases increased with submucosal invasion depth (subdistribution hazard ratio [SHR] 1.08, 95 %CI 1.02–1.14, for every increase of 500 μm), lymphovascular invasion (SHR 2.95, 95 %CI 1.95–4.45), and for larger tumors (SHR 1.23, 95 %CI 1.10–1.37, for every increase of 10 mm). The model demonstrated good discriminative ability (c-statistic 0.81, 95 %CI 0.75–0.86).

Conclusions A third of patients with pT1b EAC experienced metastases within 5 years. The probability of developing post-resection metastases was estimated with a personalized predicted risk score incorporating tumor invasion depth, tumor size, and lymphovascular invasion. This model requires external validation before implementation into clinical practice.

^* Co-first authors

^** Co-last authors

Publication History

Received: 13 July 2020

Accepted after revision: 24 February 2021

Accepted Manuscript online:
24 February 2021

Article published online:
04 May 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69: 7-34
  CrossrefPubMedSearch in Google Scholar
• 2 van der Schaaf M, Johar A, Wijnhoven B. et al. Extent of lymph node removal during esophageal cancer surgery and survival. J Natl Cancer Inst 2015; 107: djv043
  PubMedSearch in Google Scholar
• 3 Chevaux JB, Piessevaux H, Jouret-Mourin A. et al. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett’s neoplasia. Endoscopy 2015; 47: 103-112
  PubMedSearch in Google Scholar
• 4 Fitzgerald RC, di Pietro M, Ragunath K. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 2014; 63: 7-42
  CrossrefPubMedSearch in Google Scholar
• 5 Leers JM, DeMeester SR, Oezcelik A. et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg 2011; 253: 271-278
  CrossrefPubMedSearch in Google Scholar
• 6 Liu L, Hofstetter WL, Rashid A. et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 2005; 29: 1079-1085
  CrossrefPubMedSearch in Google Scholar
• 7 Barbour AP, Jones M, Brown I. et al. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol 2010; 17: 2494-2502
  CrossrefPubMedSearch in Google Scholar
• 8 Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 2012; 107: 850-862
  CrossrefPubMedSearch in Google Scholar
• 9 Spechler SJ, Sharma P, Souza RF. et al. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology 2011; 140: e18-52
  CrossrefPubMedSearch in Google Scholar
• 10 Pech O, May A, Manner H. et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 2014; 146: 652-660
  CrossrefPubMedSearch in Google Scholar
• 11 Alvarez HerreroL, Pouw RE, van Vilsteren FG. et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy 2011; 43: 177-183
  Thieme ConnectPubMedSearch in Google Scholar
• 12 Sepesi B, Watson TJ, Zhou D. et al. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg 2010; 210: 418-427
  CrossrefPubMedSearch in Google Scholar
• 13 Lee L, Ronellenfitsch U, Hofstetter WL. et al. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. J Am Coll Surg 2013; 217: 191-199
  CrossrefPubMedSearch in Google Scholar
• 14 Stein HJ, Feith M, Bruecher BL. et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005; 242: 566-575
  CrossrefPubMedSearch in Google Scholar
• 15 Westerterp M, Koppert LB, Buskens CJ. et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005; 446: 497-504
  CrossrefPubMedSearch in Google Scholar
• 16 Kaneshiro DK, Post JC, Rybicki L. et al. Clinical significance of the duplicated muscularis mucosae in Barrett esophagus-related superficial adenocarcinoma. Am J Surg Pathol 2011; 35: 697-700
  CrossrefPubMedSearch in Google Scholar
• 17 Bollschweiler E, Baldus SE, Schroder W. et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006; 38: 149-156
  Thieme ConnectPubMedSearch in Google Scholar
• 18 Linden PA, Towe CW, Watson TJ. et al. Mortality after esophagectomy: analysis of individual complications and their association with mortality. J Gastrointest Surg 2020; 24: 1948-1954
  CrossrefPubMedSearch in Google Scholar
• 19 Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med 2011; 364: 2128-2137
  CrossrefPubMedSearch in Google Scholar
• 20 Manner H, Pech O, Heldmann Y. et al. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 2013; 11: 630-635
  CrossrefPubMedSearch in Google Scholar
• 21 Manner H, May A, Pech O. et al. Early Barrett’s carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008; 103: 2589-2597
  CrossrefPubMedSearch in Google Scholar
• 22 Scholvinck D, Kunzli H, Meijer S. et al. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surg Endosc 2016; 30: 4102-4113
  CrossrefPubMedSearch in Google Scholar
• 23 Alvarez HerreroL, Pouw RE, van Vilsteren FG. et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy 2010; 42: 1030-1036
  Thieme ConnectPubMedSearch in Google Scholar
• 24 Manner H, Pech O, Heldmann Y. et al. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc 2015; 29: 1888-1896
  CrossrefPubMedSearch in Google Scholar
• 25 Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T. et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-854
  Thieme ConnectPubMedSearch in Google Scholar
• 26 Gotink AW, ten Kate FJ, Doukas M. et al. Do pathologists agree with each other on the histological assessment of pT1b oesophageal adenocarcinoma?. United European Gastroenterol J 2019; 7: 261-269
  CrossrefPubMedSearch in Google Scholar
• 27 Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th edn. 3. Lyon: International Agency for Research on Cancer; 2010
  Search in Google Scholar
• 28 The Paris endoscopic classification of superficial neoplastic lesions. esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58: S3-43
  CrossrefPubMedSearch in Google Scholar
• 29 Steyerberg EW. Clinical prediction models – a practical approach to development, validation, and updating. 2nd edn. New York: Springer-Verlag; 2009
  Search in Google Scholar
• 30 Siewert JR, Stein HJ, Feith M. et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001; 234: 360-367
  CrossrefPubMedSearch in Google Scholar
• 31 Buskens CJ, Westerterp M, Lagarde SM. et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 2004; 60: 703-710
  CrossrefPubMedSearch in Google Scholar
• 32 Graham D, Sever N, Magee C. et al. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: a retrospective single centre experience. World J Gastroenterol 2018; 24: 4698-4707
  CrossrefPubMedSearch in Google Scholar
• 33 Hosono I, Miyahara R, Furukawa K. et al. Use of immunostaining for the diagnosis of lymphovascular invasion in superficial Barrett’s esophageal adenocarcinoma. BMC Gastroenterol 2020; 20: 175
  CrossrefPubMedSearch in Google Scholar

• Supplementary Material